EUVIMEDEUVIMED entdecken
Fallbericht

A PRKCA ‐Fused Blue Melanocytoma Expressing a Truncated ALK Isoform

Hadrien Reboul, Isabelle Thibaut, Philippe Galinier, Emilie Tournier, David Grand, Frederic Escudié, Arnaud de la Fourchardière, Laurence Lamant iD

Journal of Cutaneous Pathology · 2026-12 · 53 (12) · 1097-1101

DOI: 10.1111/cup.70171 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 10.07.2026. Verfasst von Hadrien Reboul und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, University Hospital Center, IUCT-University Cancer Institute, Toulouse, France. Hauptthemen laut MEDLINE: Skin Neoplasms, Melanoma, Protein Kinase C-alpha, Receptor Protein-Tyrosine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanocytic tumors are categorized into “common,” “Spitz,” and “blue” types based on distinct genetic profiles, as recognized in the latest WHO classification. In this report, we present the first case of a PRKCA‐fused blue melanocytoma ALK‐positive in a 13‐year‐old girl, who exhibited a dome‐shaped cutaneous lesion on the tibia. The tumor demonstrated an intriguing immunostaining with ALK1A4 antibody. Targeted RNA sequencing revealed a PRKCA fusion without ALK rearrangement. But, further investigations uncovered ALK alternative transcripts resulting from an alternative transcription initiation (ATI). While the ALK truncated isoform ( ALK ATI) has been identified in a small subset of melanomas, its presence in Spitz or blue tumors has not previously been documented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsMelanomaProtein Kinase C-alphaReceptor Protein-Tyrosine KinasesOncogene Proteins, FusionHumansFemaleAdolescentAnaplastic Lymphoma KinaseProtein Isoforms

Stichwörter der Autor:innen

ALK ATI isoformmelanocytomaskin

Substanzen

Anaplastic Lymphoma KinaseALK protein, humanPRKCA protein, humanProtein Kinase C-alphaProtein IsoformsReceptor Protein-Tyrosine KinasesOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Pathology Department, University Hospital Center, IUCT-University Cancer Institute, Toulouse, France.
  • Pathology Center of Coteaux, Toulouse, France.
  • Pediatric Surgery Office of the Rive Gauche Clinic, Toulouse, France.
  • Department of Biopathology, Centre Leon Berard, Lyon, France.
  • Department of Research, University of Lyon, Universite Claude Bernard Lyon 1, Cancer Research Centre of Lyon, Lyon, France.
  • Toulouse University, Toulouse, France.

ORCID-Profile: Laurence Lamant

Zitieren

APA

Reboul, H., Thibaut, I., Galinier, P., Tournier, E., Grand, D., Escudié, F., de la Fourchardière, A., & Lamant, L. (2026). A PRKCA ‐Fused Blue Melanocytoma Expressing a Truncated ALK Isoform. Journal of Cutaneous Pathology, 53(12), 1097-1101. https://doi.org/10.1111/cup.70171

Vancouver

Reboul H, Thibaut I, Galinier P, Tournier E, Grand D, Escudié F, et al. A PRKCA ‐Fused Blue Melanocytoma Expressing a Truncated ALK Isoform. Journal of Cutaneous Pathology. 2026;53(12):1097-1101. doi:10.1111/cup.70171

BibTeX
@article{Reboul2026,
  author = {Reboul, Hadrien and Thibaut, Isabelle and Galinier, Philippe and Tournier, Emilie and Grand, David and Escudié, Frederic and de la Fourchardière, Arnaud and Lamant, Laurence},
  title = {A PRKCA ‐Fused Blue Melanocytoma Expressing a Truncated ALK Isoform},
  journal = {Journal of Cutaneous Pathology},
  year = {2026},
  volume = {53},
  number = {12},
  pages = {1097--1101},
  doi = {10.1111/cup.70171}
}
Kostenlos starten →